Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of 4d Molecular Therapeutics, Inc. (FDMT) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of 4d Molecular Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1650648.
Total stock buying since 2020: $51,074,981.
Total stock sales since 2020: $23,827,643.
Total stock option exercises since 2020: $1,317,368.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 788,801 | $16,732,732 | 81,583 | $1,119,814 |
| 2023 | 850,000 | $13,600,000 | 104,299 | $2,024,550 | 19,250 | $159,914 |
| 2022 | 0 | $0 | 86,877 | $2,027,326 | 3,000 | $28,230 |
| 2021 | 0 | $0 | 98,785 | $3,043,035 | 1,000 | $9,410 |
| 2020 | 1,629,347 | $37,474,981 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-09 | 0 | $0 | 500 | $8,164 | 500 | $3,245 |
| 2024-08 | 0 | $0 | 500 | $7,500 | 500 | $3,245 |
| 2024-07 | 0 | $0 | 20,917 | $478,699 | 20,917 | $270,207 |
| 2024-06 | 0 | $0 | 14,680 | $340,202 | 14,680 | $199,163 |
| 2024-05 | 0 | $0 | 1,750 | $44,709 | 1,750 | $12,713 |
| 2024-04 | 0 | $0 | 1,750 | $45,045 | 1,750 | $12,713 |
| 2024-03 | 0 | $0 | 7,583 | $259,133 | 7,583 | $164,254 |
| 2024-02 | 0 | $0 | 126,456 | $3,510,992 | 33,903 | $454,274 |
| 2024-01 | 0 | $0 | 614,665 | $12,038,288 | 0 | $0 |
| 2023-12 | 0 | $0 | 33,334 | $579,688 | 0 | $0 |
| 2023-06 | 0 | $0 | 5,997 | $119,329 | 5,625 | $42,317 |
| 2023-05 | 850,000 | $13,600,000 | 0 | $0 | 3,000 | $28,230 |
| 2023-04 | 0 | $0 | 8,750 | $175,269 | 8,750 | $77,199 |
| 2023-03 | 0 | $0 | 2,248 | $43,386 | 1,875 | $12,168 |
| 2023-02 | 0 | $0 | 34,446 | $714,398 | 0 | $0 |
| 2023-01 | 0 | $0 | 19,524 | $392,480 | 0 | $0 |
| 2022-12 | 0 | $0 | 86,877 | $2,027,326 | 3,000 | $28,230 |
| 2021-10 | 0 | $0 | 36,285 | $1,137,814 | 0 | $0 |
| 2021-09 | 0 | $0 | 62,500 | $1,905,221 | 0 | $0 |
| 2021-04 | 0 | $0 | 0 | $0 | 1,000 | $9,410 |
| 2020-12 | 1,629,347 | $37,474,981 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-16 | Bizily Scott (Chief Legal Officer) | Sale | 500 | 16.33 | 8,164 |
| 2024-09-16 | Bizily Scott (Chief Legal Officer) | Option Ex | 500 | 6.49 | 3,245 |
| 2024-08-19 | Bizily Scott (Chief Legal Officer) | Sale | 500 | 15.00 | 7,500 |
| 2024-08-19 | Bizily Scott (Chief Legal Officer) | Option Ex | 500 | 6.49 | 3,245 |
| 2024-07-16 | Bizily Scott (Chief Legal Officer) | Sale | 1,750 | 27.11 | 47,442 |
| 2024-07-16 | Bizily Scott (Chief Legal Officer) | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-07-11 | Bizily Scott (Chief Legal Officer) | Sale | 1,996 | 25.00 | 49,900 |
| 2024-07-11 | Bizily Scott (Chief Legal Officer) | Option Ex | 1,996 | 15.78 | 31,496 |
| 2024-07-10 | Kirn David (Chief Executive Officer) | Sale | 12,923 | 22.49 | 290,599 |
| 2024-07-10 | Kirn David (Chief Executive Officer) | Option Ex | 12,923 | 15.10 | 195,137 |
| 2024-07-01 | Bizily Scott (Chief Legal Officer) | Sale | 4,248 | 21.36 | 90,758 |
| 2024-07-01 | Bizily Scott (Chief Legal Officer) | Option Ex | 4,248 | 7.26 | 30,861 |
| 2024-06-24 | Kirn David (Chief Executive Officer) | Sale | 12,930 | 23.10 | 298,708 |
| 2024-06-24 | Kirn David (Chief Executive Officer) | Option Ex | 12,930 | 14.42 | 186,450 |
| 2024-06-17 | Bizily Scott (Chief Legal Officer) | Sale | 1,750 | 23.71 | 41,494 |
| 2024-06-17 | Bizily Scott (Chief Legal Officer) | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-05-16 | Bizily Scott (Chief Legal Officer) | Sale | 1,750 | 25.55 | 44,709 |
| 2024-05-16 | Bizily Scott (Chief Legal Officer) | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-04-16 | Bizily Scott (Chief Legal Officer) | Sale | 1,750 | 25.74 | 45,045 |
| 2024-04-16 | Bizily Scott (Chief Legal Officer) | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-03-27 | Bizily Scott (Chief Legal Officer) | Sale | 5,833 | 35.04 | 204,411 |
| 2024-03-27 | Bizily Scott (Chief Legal Officer) | Option Ex | 5,833 | 25.98 | 151,541 |
| 2024-03-18 | Bizily Scott (Chief Legal Officer) | Sale | 1,750 | 31.27 | 54,722 |
| 2024-03-18 | Bizily Scott (Chief Legal Officer) | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-02-27 | Bizily Scott (Chief Legal Officer) | Sale | 1,909 | 30.00 | 57,270 |
| 2024-02-27 | Bizily Scott (Chief Legal Officer) | Option Ex | 1,909 | 20.24 | 38,638 |
| 2024-02-16 | Bizily Scott (Chief Legal Officer) | Sale | 1,750 | 27.67 | 48,422 |
| 2024-02-16 | Bizily Scott (Chief Legal Officer) | Option Ex | 1,750 | 7.26 | 12,713 |
| 2024-02-08 | Bizily Scott (Chief Legal Officer) | Sale | 6,244 | 27.50 | 171,710 |
| 2024-02-08 | Bizily Scott (Chief Legal Officer) | Option Ex | 6,244 | 10.10 | 63,083 |
| 2024-02-08 | Kirn David (Chief Executive Officer) | Sale | 92,001 | 27.13 | 2,495,803 |
| 2024-02-05 | Kim Robert Young (Chief Medical Officer) | Sale | 24,552 | 30.05 | 737,787 |
| 2024-02-05 | Kim Robert Young (Chief Medical Officer) | Option Ex | 24,000 | 14.16 | 339,840 |
| 2024-01-23 | Kirn David (Chief Executive Officer) | Sale | 5,696 | 18.41 | 104,851 |
| 2024-01-05 | Kirn David (Chief Executive Officer) | Sale | 28,237 | 19.83 | 560,052 |
| 2024-01-04 | Kirn David (Chief Executive Officer) | Sale | 40,732 | 20.31 | 827,185 |
| 2024-01-04 | Shabet Rose Sharon | Sale | 540,000 | 19.53 | 10,546,200 |
| 2023-12-18 | Kirn David (Chief Executive Officer) | Sale | 4,702 | 18.13 | 85,242 |
| 2023-12-15 | Kirn David (Chief Executive Officer) | Sale | 28,632 | 17.27 | 494,446 |
| 2023-06-08 | Bizily Scott (Chief Legal and HR Officer) | Sale | 3,750 | 20.85 | 78,187 |
| 2023-06-08 | Bizily Scott (Chief Legal and HR Officer) | Option Ex | 3,750 | 8.04 | 30,149 |
| 2023-06-01 | Bizily Scott (Chief Legal and HR Officer) | Sale | 2,247 | 18.31 | 41,142 |
| 2023-06-01 | Bizily Scott (Chief Legal and HR Officer) | Option Ex | 1,875 | 6.49 | 12,168 |
| 2023-05-15 | Moretti August J (Chief Financial Officer) | Option Ex | 3,000 | 9.41 | 28,230 |
| 2023-05-09 | Shabet Rose Sharon | Buy | 850,000 | 16.00 | 13,600,000 |
| 2023-04-21 | Bizily Scott (Chief Legal and HR Officer) | Sale | 3,750 | 20.00 | 75,000 |
| 2023-04-21 | Bizily Scott (Chief Legal and HR Officer) | Option Ex | 3,750 | 8.04 | 30,149 |
| 2023-04-21 | Chacko Jacob | Sale | 5,000 | 20.05 | 100,269 |
| 2023-04-21 | Chacko Jacob | Option Ex | 5,000 | 9.41 | 47,050 |
| 2023-03-01 | Bizily Scott (Chief Legal and HR Officer) | Sale | 2,248 | 19.30 | 43,386 |
| 2023-03-01 | Bizily Scott (Chief Legal and HR Officer) | Option Ex | 1,875 | 6.49 | 12,168 |
| 2023-02-22 | Kirn David (Chief Executive Officer) | Sale | 16,449 | 20.22 | 332,664 |
| 2023-02-21 | Kirn David (Chief Executive Officer) | Sale | 17,997 | 21.21 | 381,734 |
| 2023-01-20 | Kirn David (Chief Executive Officer) | Sale | 8,625 | 20.19 | 174,130 |
| 2023-01-19 | Kirn David (Chief Executive Officer) | Sale | 10,899 | 20.03 | 218,350 |
| 2022-12-21 | Moretti August J (Chief Financial Officer) | Option Ex | 3,000 | 9.41 | 28,230 |
| 2022-12-16 | Kirn David (Chief Executive Officer) | Sale | 53,944 | 23.02 | 1,242,006 |
| 2022-12-15 | Kirn David (Chief Executive Officer) | Sale | 32,933 | 23.85 | 785,320 |
| 2021-10-22 | Schaffer David | Sale | 1,900 | 31.00 | 58,892 |
| 2021-10-21 | Schaffer David | Sale | 22,820 | 31.56 | 720,153 |
| 2021-10-20 | Schaffer David | Sale | 11,565 | 31.02 | 358,769 |
| 2021-09-30 | Schaffer David | Sale | 12,385 | 26.98 | 334,209 |
| 2021-09-29 | Schaffer David | Sale | 16,871 | 29.04 | 489,883 |
| 2021-09-28 | Schaffer David | Sale | 13,912 | 31.26 | 434,861 |
| 2021-09-27 | Schaffer David | Sale | 19,332 | 33.43 | 646,268 |
| 2021-04-12 | Moretti August J (Chief Financial Officer) | Option Ex | 1,000 | 9.41 | 9,410 |
| 2020-12-15 | Kamal Fariborz (See Remarks) | Buy | 4,347 | 23.00 | 99,981 |
| 2020-12-15 | Yao Tony Dung Ling | Buy | 425,000 | 23.00 | 9,775,000 |
| 2020-12-15 | Shabet Rose Sharon | Buy | 1,100,000 | 23.00 | 25,300,000 |
| 2020-12-15 | Milligan John F | Buy | 100,000 | 23.00 | 2,300,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of FDMT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of 4d Molecular Therapeutics, Inc. (symbol FDMT, CIK number 1650648) see the Securities and Exchange Commission (SEC) website.